Texas Instruments (TXN) Earns Sell Rating from Analysts at UBS

UBS initiated coverage on shares of Texas Instruments (NASDAQ:TXN) in a report released on Wednesday morning, www.benzinga.com reports. The brokerage issued a sell rating and a $85.00 price target on the semiconductor company’s stock.

Several other research analysts also recently weighed in on the stock. Zacks Investment Research raised shares of Texas Instruments from a hold rating to a buy rating and set a $113.00 target price on the stock in a research report on Tuesday. ValuEngine downgraded shares of Texas Instruments from a buy rating to a hold rating in a research report on Monday, April 2nd. Longbow Research assumed coverage on shares of Texas Instruments in a research report on Tuesday, March 27th. They issued a neutral rating on the stock. Credit Suisse Group raised shares of Texas Instruments to a buy rating and set a $125.00 target price on the stock in a research report on Wednesday, February 7th. Finally, Argus lifted their target price on shares of Texas Instruments to $122.00 and gave the stock a buy rating in a research report on Thursday, January 25th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. The company has a consensus rating of Buy and an average target price of $109.96.

How to Become a New Pot Stock Millionaire

Shares of TXN opened at $99.46 on Wednesday. The company has a market capitalization of $102,520.50, a PE ratio of 23.24, a price-to-earnings-growth ratio of 2.17 and a beta of 1.24. The company has a debt-to-equity ratio of 0.35, a quick ratio of 3.00 and a current ratio of 3.87. Texas Instruments has a 12-month low of $75.92 and a 12-month high of $120.75.

Texas Instruments (NASDAQ:TXN) last announced its quarterly earnings data on Tuesday, January 23rd. The semiconductor company reported $1.09 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.09. The company had revenue of $3.75 billion for the quarter, compared to analysts’ expectations of $3.74 billion. Texas Instruments had a net margin of 24.61% and a return on equity of 40.83%. The business’s revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS. research analysts forecast that Texas Instruments will post 4.99 EPS for the current fiscal year.

In related news, insider Stephen A. Anderson sold 141,638 shares of the firm’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $111.12, for a total transaction of $15,738,814.56. Following the completion of the sale, the insider now directly owns 178,200 shares in the company, valued at $19,801,584. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Haviv Ilan sold 23,831 shares of Texas Instruments stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $110.36, for a total transaction of $2,629,989.16. Following the completion of the sale, the vice president now owns 131,153 shares of the company’s stock, valued at $14,474,045.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 757,632 shares of company stock valued at $83,306,399. 0.84% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Garde Capital Inc. lifted its stake in Texas Instruments by 12.6% in the fourth quarter. Garde Capital Inc. now owns 5,351 shares of the semiconductor company’s stock valued at $559,000 after acquiring an additional 598 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Texas Instruments by 2.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 55,212 shares of the semiconductor company’s stock valued at $5,766,000 after acquiring an additional 1,529 shares during the last quarter. Wagner Wealth Management LLC acquired a new stake in Texas Instruments in the fourth quarter valued at approximately $205,000. Colonial Trust Advisors acquired a new stake in Texas Instruments in the fourth quarter valued at approximately $488,000. Finally, Xact Kapitalforvaltning AB lifted its stake in Texas Instruments by 14.1% in the fourth quarter. Xact Kapitalforvaltning AB now owns 92,512 shares of the semiconductor company’s stock valued at $9,662,000 after acquiring an additional 11,433 shares during the last quarter. Hedge funds and other institutional investors own 85.16% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3338026/texas-instruments-txn-earns-sell-rating-from-analysts-at-ubs.html.

About Texas Instruments

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates in two segments, Analog and Embedded Processing. The Analog segment offers power products to manage power requirements in various levels using battery management solutions, portable components, power supply controls, point-of-load products, switches and interfaces, integrated protection devices, high-voltage products, and mobile lighting and display products.

Analyst Recommendations for Texas Instruments (NASDAQ:TXN)

Receive News & Ratings for Texas Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Instruments and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

New Age Beverages  Stock Price Down 9.4% on Analyst Downgrade
New Age Beverages Stock Price Down 9.4% on Analyst Downgrade
Scotiabank Reiterates C$4.75 Price Target for Premier Gold Mines
Scotiabank Reiterates C$4.75 Price Target for Premier Gold Mines
BMO Capital Markets Increases Roots  Price Target to C$16.00
BMO Capital Markets Increases Roots Price Target to C$16.00
Syntel  Trading -0.6% Higher  After Strong Earnings
Syntel Trading -0.6% Higher After Strong Earnings
BNP Paribas Reiterates CHF 74 Price Target for Nestle
BNP Paribas Reiterates CHF 74 Price Target for Nestle
Roche  Given a CHF 230 Price Target at Morgan Stanley
Roche Given a CHF 230 Price Target at Morgan Stanley


Leave a Reply

© 2006-2018 Ticker Report. Google+.